The role of pharmacists in managing conditions like hypertension: The case of Northern Cyprus

Abstract :

Hypertension is a high-risk factor for cardiovascular diseases and its prevalence rate is increasing due to risk factors such as unhealthy lifestyles and aging populations. Managing hypertension is crucial to avoid complications such as stroke, heart failure, and kidney failure. In Northern Cyprus, where hypertension is a growing public health concern, pharmacists are increasingly recognized as key players in managing this ongoing condition. This study investigates the impact of pharmacists in controlling hypertension in Northern Cyprus through a survey-based observational approach. Data were collected from 70 hypertension patients engaging with community pharmacists. The results highlight pharmacists’ contributions to patient education, blood pressure monitoring, and medication adherence. Relevant studies in other countries contextualize the findings about the importance of the pharmacist role. An analysis of the data confirms significant improvements in patient outcomes with pharmacist interventions. The survey results provide insights suggesting that overcoming systemic barriers and strengthening collaboration can optimize pharmacists' roles in managing hypertension in Northern Cyprus.

References

1. Sawicka KM, Szczyrek M, Jastrzębska I, Prasał M, Zwolak A, Daniluk J. Hypertension - The silent killer. Journal of Pre-Clin and Clinical Research. 2011; 5(2): 43-46. Corpus ID: 68380773.
2. Kario K, Okura A, Hoshide S, Mogi M. The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertension Research. 2024; 47: 1099-1102. doi: 10.1038/s41440-024-01622-w
3. Miezah D, Hayman LL. Culturally tailored lifestyle modification strategies for hypertension management: A narrative review. American Journal of Lifestyle and Medicine. 2024; 6. doi: 10.1177/15598276241297675
4. Rafi IK, Rahman Md. A study about factors related to the degree of knowledge regarding hypertension in Kishoreganj, Bangladesh. Mediterranean Journal of Medical Research. 2025; 2: 1-5. doi. 10.5281/zenodo. 15091123
5. Berksel E, Özduran G, Süer HK, Aykaç A. A cross-sectional study of hypertension prevalence, awareness, treatment, ratios under control and related factors in Turkish Cypriot individuals living in North Cyprus. Cyprus Journal of Medical Science. 2024; 9(3): 173-179. doi: 10.4274/cjms.2024.2023-96
6. Aboulqassim NSS, Alterkawy AO, Alhosny BM, Alqtany FA, Alawamy OA, El.mabri ZM. Range of cardiovascular medications dispensing practice without a prescription: A cross-section study on pharmacists at community pharmacies in Libya. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(2): 131-140. doi: 10.5281/zenodo15650755
7. Elfituri AA, Sherif FM. Novel clinical pharmacy practice: Extended role and improved competencies. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(1): 1-3. doi: 10.5281/zenodo.6397651
8. Al-Sharif SM, Elmezughi SO, Sherif FM. Implementation of good pharmacy practice standards; a step forward in Libya's pharmacies. Iberoamerican Journal of Medicine. 2020; 2(4): 377-380. doi: 10.5281/zenodo.4095782
9. Charalampous P, Peletidi A. Exploring Cypriot pharmacists' perceptions about their role in cardiovascular disease prevention: A descriptive qualitative study. Journal of Research Pharm and Practice. 2021; 10(1): 23-29. doi: 10.4103/jrpp.JRPP_20_102
10. Soubra L, Elba G. Pharmacist role in hypertension management in the community setting: Questionnaire development, validation, and application. Patient Preference and Adherence. 2023; 17: 351-367. doi: 10.2147/ PPA.S394855
11. Goksin S, Abdi A, Alsaloumi L, Basgut B. Drug-related problems and health-related quality of life among chronic disease patients in a rural region of North Cyprus. Tropical Journal of Pharmaceutical Research. 2022; 21(10): 2183-2194. doi: 10.4314/tjpr.v21i10.20
12. Peletidi A, Nabhani-Gebara S, Kayyali R. The role of pharmacists in cardiovascular disease prevention: Qualitative studies from the United Kingdom and Greece. Journal of Research in Pharmacy Practice. 2019; 8(3): 112-122. doi: 10.4103/jrpp.JRPP_19_3
13. Emmerton LM, Smith L, LeMay KS, Krass I, Saini B, Bosnic-Anticevich SZ, Reddel HK, Burton DL, Stewart K, Armour CL. Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia. BMC Health Services and Research. 2012; 12: 164. doi: 10.1186/1472-6963-12-164h
14. Azhar S, Hassali MA, Ibrahim MIM, Masood I, Shafie AA. The role of pharmacists in developing countries: The current scenario in Pakistan. Human Resources for Health. 2009; 7: 54. doi: 10.1186/1478-4491-7-54
15. Smith F. Private local pharmacies in low- and middle-income countries: a review of interventions to enhance their role in public health. Tropical Medicine and International Health. 2009; 14(3): 362-372. doi: 10.1111/j.1365-3156 .2009.02232.x
16. Saavedra-Mitjans M, Ferrand É, Garin N, Bussierres J-F. Role and impact of pharmacists in Spain: a scoping review. International Journal of Clinical Pharmacy. 2018; 40(6): 1430-1442. doi: 10.1007/s11096-018-0740-7
17. El Hajj MS, Mahfoud ZR, Al Suwaidi J, Alkhiyami D, Alasmar AR. Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: A cross-sectional study in the State of Qatar. Journal of Evaluation in Clinical Practice. 2016. 22(3): 329-340. doi: 10.1111/jep.12477
18. Hudson SA, McAnaw JJ, Johnson BJ. The changing roles of pharmacists in society. International e-Journal of Science, Medicine, and Eduction.2007; 1(1): 22-34. doi: Nil.
19. Alssageer MA, Khattab BF, Bakouri AH. Physicians' attitudes, expectations, and experiences about clinical pharmacists and the barriers they have in developing a collaborative relationship with them. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4(3): 27-38. doi: 10.5281/zenodo.13324209
20. Tekin ÇS. The role of community pharmacists in public health and public health-related problems which they encounter. Istanbul Journal of Pharmacy. 2020; 50920: 142-148. doi: 10.26650/IstanbulJPharm.2019.0069
21. Jaaida NA, Alameer EM, Allafee AA. Assessment of current community pharmacist labeling practice: A simulated client approaches. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4(3): 1-6. doi: 10.5281/zenodo.13254724
22. Jamiu MO, Danjuma NM, Giwa A. Educational intervention on knowledge of hypertension and lifestyle/dietary modification among hypertensive patients attending a tertiary health facility in Nigeria. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4(1): 1-11. doi. 10.5281/zenodo.10535778
23. Marfo AFA, Owusu-Daaku FT. Exploring the extended role of the community pharmacist in improving blood pressure control among hypertensive patients in a developing setting. Journal of Pharmaceutical Policy and Practice. 2017; 10: 39. doi: 10.1186/s40545-017-0127-5
24. Li Y, Liu G, Liu C, Wang X, Chu Y, Li X, Yang W, et al. Effects of pharmacist intervention on community control of hypertension: A randomized controlled trial in Zunyi, China. Global Health: Science and Practice. 2021; 9(4): 890-904. doi: 10.9745/GHSP-D-20-00505
25. Lawal BK, Mohammed S, Alhaji AA, Maiha BB, Ladan MA, Ibrahim UI. Barriers and enablers of medication safety: A qualitative study from public hospitals in Kaduna State, Nigeria. Pharmacy Education. 2024; 24(1): 322-331. doi: 10.46542/pe.2024.241.322331
26. Eades CE, Ferguson JS, O'Carroll RE. Public health in community pharmacy: A systematic review of pharmacist and consumer views. BMC Public Health. 2011; 11(1): 582. doi: 10.1186/1471-2458-11-582
27. Rupp MT, DeYoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. Medical Care. 1992; 30(10): 926-940. doi: 10.1097/00005650-199210000-00005
28. Sherif FM. Education and practice of pharmacy in Libya. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(3): 1-2. doi: 10.5281/zenodo.7115078
29. Alssageer MA, Mohammed ES, Abd-Alsalm SA. Prevalence of comorbidity and polypharmacy among hospitalized elderly patients. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(1): 53-61. doi. 10.5281/zenodo.6399521
30. Luisetto M, Ferraiuolo A, Fiazza C, Cabianca L, Edbey K, Mashori G, Latyshev OY (2025) Artificial intelligence in the pharmaceutical galenic field: A useful instrument and risk consideration. Mediterranean Journal of Medical Research. 2025; 2: 11-19. doi: 10.5281/zenodo.15259824
31. Ibraheim Alshaiby WM, Ishrayhah MA, Ghnaia MA, Elozi MK. Assessment of knowledge and attitude of pharmacists toward the side effects of anesthetics in patients with hypertension: a cross-sectional study. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2023; 3(4): 97-105. doi. 10.5281/zenodo. 10443250
32. Elmiladi SA, Elgdhafi EO. Prevalence of cardiovascular risk factors in Libyan patients with type 2 diabetes mellitus. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2023; 3(2): 27-33. doi: 10.5281/ zenodo.7877416
33. Ahmad K, Ang K, Wong P, Alimin N, Houng I, Chai Sh, Lawrence B, Chuo Yew C. Exploring patient's experiences with a pharmacy drive-through medication dispensing service: A qualitative study. Malaysian Journal of Pharmacy. 2023; 9: 16-21. doi: 10.52494/CDZM4052
34. Robinson JD, Segal R, Lopez LM, Doty RE. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Annals of Pharmacotherapy. 2010; 44(1): 88-96. doi: 10.1345/aph.1L289
35. Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: A systematic review and meta-analysis of randomized controlled trials. British Journal of Clinical Pharmacology. 2014; 78(6): 1238-1247. doi: 10.1111/bcp.12452
36. Khan MU, Shah S, Hameed T. Barriers to and determinants of medication adherence among hypertensive patients attended National Health Service Hospital, Sunderland. Journal of Pharmacy and Bioallied Sciences. 2014; 6(2): 104-108. doi. 10.4103/0975-7406.129175
37. Alssageer MA, Sherif FM, Mohammed ES, Abd Alsalm SA. Patterns of drug-prescribed and drug-related problems among hospitalized elderly patients. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences.2022; 2(2): 64-76. doi: 10.5281/zenodo.6780506
38. Sherif FM. Nicotine dependence and role of pharmacist in nicotine addiction control. Libyan international Medical University Journal. 2017; 2: 3-11. doi: 10.21502/limuj.002.02.2017
39. Cochran WG. Sampling Techniques. 3rd ed. Wiley; 1977. ISBN: 978-0471162407.
40. Moore DS, McCabe GP, Craig BA. Introduction to the Practice of Statistics. 1st Ed., New York: W.H. Freeman and Company; 2017. ISBN-13: 978-1-4292-1623-4.
41. Chonko K, Axtell S, Mayzel B. Pharmacist hypertension management quality review at an ambulatory care clinic. Journal of Pharmaceutical Technology. 2022; 38(1): 31-38. doi: 10.1177/87551225211064240
42. Abdi A, Zarouri A, Alsaloumi L, Basgut B, Bilgen S. North Cyprus pharmacist’s cognition and practice of pharmaceutical care. Journal of Pharmaceutical Research International. 2018; 21: 1-9. doi: 10.9734/JPRI/2018/ 39051
43. Ekincioglu AB, Demirkan K. Opinions of community pharmacists about collaboration with general practitioners: A descriptive pilot study after new legislation in Turkey. Turkish Journal of Pharmaceutical Sciences. 2018; 15(2): 212-218. doi: 10.4274/tjps.55376
44. Petrou P, Kelepouri P, Petrou C. Evaluating Greek pharmacists’ attitudes and barriers regarding medicines adherence. Journal of Pharmaceutical Policy and Practice. 2024; 17(1): 2319746. doi: 10.1080/20523211.2024. 2319746

Citation :

Taghizadeh P (2025) The role of pharmacists in managing conditions like hypertension: The case of Northern Cyprus. Mediterr J Pharm Pharm Sci. 5(3): 28-37. [Article number: 216]. https://doi.org/10.5281/zenodo.15921080